4.8 Article

CSDE1 attenuates microRNA-mediated silencing of PMEPA1 in melanoma

Journal

ONCOGENE
Volume 40, Issue 18, Pages 3231-3244

Publisher

SPRINGERNATURE
DOI: 10.1038/s41388-021-01767-9

Keywords

-

Funding

  1. Canadian Institutes of Health Research (CIHR)
  2. Fonds de Recherche du Quebec-Sante (FRQ-S)
  3. CIHR [FDN-143213]
  4. Spanish Ministry of Science and Innovation (MICINN) [PGC2018-099697-B-I00]
  5. la Caixa Foundation [100010434, LCF/PR/HR17/52150016]
  6. Catalan Government [2017SGR534]
  7. Center of Excellence Severo Ochoa

Ask authors/readers for more resources

The study reveals that CSDE1 interacts with miRNA-induced silencing complex miRISC in melanoma, affecting the expression of PMEPA1 gene by binding with AGO2. Additionally, miRNA miR-129-5p also represses PMEPA1 expression in melanoma, collectively regulating the impact of PMEPA1 on the progression of melanoma.
MicroRNAs and RNA-binding proteins (RBPs) primarily target the 3 ' UTR of mRNAs to control their translation and stability. However, their co-regulatory effects on specific mRNAs in physiology and disease are yet to be fully explored. CSDE1 is an RBP that promotes metastasis in melanoma and mechanisms underlying its oncogenic activities need to be completely defined. Here we report that CSDE1 interacts with specific miRNA-induced silencing complexes (miRISC) in melanoma. We find an association of CSDE1 with AGO2, the essential component of miRISC, which is facilitated by target mRNAs and depends on the first cold shock domain of CSDE1. Both CSDE1 and AGO2 bind to 3 ' UTR of PMEPA1. CSDE1 counters AGO2 binding, leading to an increase of PMEPA1 expression. We also identify a miRNA, miR-129-5p, that represses PMEPA1 expression in melanoma. Collectively, our results show that PMEPA1 promotes tumorigenic traits and that CSDE1 along with miR-129-5p/AGO2 miRISC act antagonistically to fine-tune PMEPA1 expression toward the progression of melanoma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available